Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$533M |
| 2 |
Apple
AAPL
|
+$347M |
| 3 |
Micron Technology
MU
|
+$272M |
| 4 |
Eli Lilly
LLY
|
+$232M |
| 5 |
Super Micro Computer
SMCI
|
+$185M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$472M |
| 2 |
NVIDIA
NVDA
|
+$413M |
| 3 |
Tesla
TSLA
|
+$403M |
| 4 |
Coinbase
COIN
|
+$236M |
| 5 |
Johnson & Johnson
JNJ
|
+$224M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.66% |
| 2 | Healthcare | 16.81% |
| 3 | Consumer Discretionary | 13.04% |
| 4 | Industrials | 9.63% |
| 5 | Financials | 9.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
HAPN
2026
Happen Inc
HAPN
$2.31B
| $2M | ﹤0.01% |
174,705
-435,520
| -71% | -$4.65M |
|
2027
Atossa Therapeutics
ATOS
$23M
| $1.99M | ﹤0.01% |
87,338
-16,056
| -16% | -$324K |
|
|
ONT
2028
Onterris Inc
ONT
$511M
| $1.98M | ﹤0.01% |
75,450
+41,450
| +122% | +$1.34M |
|
|
PRO
2029
DELISTED
PROS Holdings
PRO
| $1.98M | ﹤0.01% |
106,900
+4,500
| +4% | +$95.1K |
|
2030
Saga Communications
SGA
$58.5M
| $1.97M | ﹤0.01% |
137,037
+14,293
| +12% | +$214K |
|
|
HMNF
2031
DELISTED
HMN Financial Inc
HMNF
| $1.97M | ﹤0.01% |
70,525
-1,800
| -2% | -$46K |
|
2032
Dana Inc
DAN
$3.02B
| $1.97M | ﹤0.01% |
186,200
-178,600
| -49% | -$1.97M |
|
2033
CVB Financial
CVBF
$4.01B
| $1.96M | ﹤0.01% |
110,194
-1,500
| -1% | -$26.8K |
|
2034
Greif Class B
GEF.B
$4.3B
| $1.96M | ﹤0.01% |
28,100
-6,300
| -18% | -$416K |
|
2035
Vicor
VICR
$10.3B
| $1.96M | ﹤0.01% |
46,500
-30,300
| -39% | -$1.13M |
|
2036
Resources Connection
RGP
$149M
| $1.96M | ﹤0.01% |
201,642
-119,472
| -37% | -$1.23M |
|
|
IVAC
2037
DELISTED
Intevac Inc
IVAC
| $1.96M | ﹤0.01% |
575,173
+24,996
| +5% | +$91K |
|
2038
Harvard Bioscience
HBIO
$28.2M
| $1.95M | ﹤0.01% |
72,408
-2,120
| -3% | -$62.5K |
|
2039
Zillow
ZG
$7.25B
| $1.94M | ﹤0.01% |
+31,400
| New | +$1.63M |
|
2040
RF Industries
RFIL
$141M
| $1.94M | ﹤0.01% |
476,308
-8,500
| -2% | -$32.6K |
|
|
TBCH
2041
Turtle Beach Corp
TBCH
$246M
| $1.94M | ﹤0.01% |
126,628
-137,100
| -52% | -$2M |
|
2042
Air T
AIRT
$89.4M
| $1.94M | ﹤0.01% |
120,111
+1,600
| +1% | +$36K |
|
2043
Palomar
PLMR
$3.6B
| $1.94M | ﹤0.01% |
+20,500
| New | +$1.89M |
|
|
SEVN
2044
Seven Hills Realty Trust
SEVN
$176M
| $1.94M | ﹤0.01% |
140,834
+8,434
| +6% | +$113K |
|
2045
Benchmark Electronics
BHE
$2.99B
| $1.94M | ﹤0.01% |
43,700
-5,400
| -11% | -$225K |
|
|
BDN
2046
Brandywine Realty Trust
BDN
$560M
| $1.93M | ﹤0.01% |
354,036
+258,038
| +269% | +$1.28M |
|
2047
Vanguard Russell 1000 ETF
VONE
$8.51B
| $1.92M | ﹤0.01% |
7,400
-2,100
| -22% | -$526K |
|
2048
Lamar Advertising Co
LAMR
$16.4B
| $1.92M | ﹤0.01% |
+14,400
| New | +$1.76M |
|
2049
Wyndham Hotels & Resorts
WH
$5.61B
| $1.92M | ﹤0.01% |
24,600
-25,900
| -51% | -$1.97M |
|
2050
Nutrien
NTR
$32B
| $1.92M | ﹤0.01% |
+39,985
| New | +$1.93M |
|
Similar funds
Renaissance Technologies's Q3 2024 Portfolio in Review
As of Q3 2024, Renaissance Technologies held 4,024 positions worth $66.5B, up 13% from $59B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Renaissance Technologies deployed $3.2B of net new capital in Q3 2024, opening 578 new positions and adding to 1,558 existing holdings. Its largest new stake was Micron Technology: 2,604,914 shares worth $270M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 20% a quarter earlier, followed by Healthcare and Consumer Discretionary.
On the sell side, the largest reduction was NVIDIA, an estimated $413M trimmed.
- Renaissance Technologies's largest Q3 2024 buy was Micron Technology: 2,604,914 shares worth $270M.
- Renaissance Technologies added most to Microsoft in Q3 2024, an estimated $533M increase.
- Renaissance Technologies's biggest Q3 2024 reduction was NVIDIA, cutting an estimated $413M.
- Renaissance Technologies fully exited Broadcom in Q3 2024, selling an estimated $472M.
- Renaissance Technologies's ten largest holdings make up 11% of its $66.5B portfolio in Q3 2024.
- Renaissance Technologies opened 578 new positions and closed 539 in Q3 2024.
- Renaissance Technologies's portfolio value rose 13% quarter-over-quarter to $66.5B.
Based on Renaissance Technologies's 13F filing for Q3 2024, filed 13 Nov 2024.